Clinical efficacy of traditional chinese medicine on acute myocardial infarction—A prospective cohort study

Duan, Weijia; Lü, Fang; Liu, Lizhi; Wang, Chenglong; Liu, Jiangang; Yang, Qiaoning; Gu, Feng; Zhang, Lei; Shi, Dazhuo

doi:10.1007/s11655-012-1116-9

Cited by 8 publications

(5 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The rise in use may reflect even more government investment in preserving TCM, including more research on the effectiveness of TCM as well as broad insurance coverage for intravenous TCMs, which may influence the public’s perceptions about the benefits and safety of TCM. 14 Several recent studies published in the Chinese literature and in complementary medicine journals show improved biological and clinical outcomes, including improved angiographic coronary blood flow and reflow, 21 , 22 decreased stent restenosis, shorter hospital stays, less angina, 23 fewer readmissions, 23 improved quality of life, and improved short- and long-term mortality. 5 , 24 In the case of Salvia miltiorrhiza/danshen, the most widely used TCM, there are reports of superior efficacy and fewer side effects than nitroglycerin for the treatment of angina.…”

Section: Discussionmentioning

confidence: 99%

Traditional Chinese Medicine for Acute Myocardial Infarction in Western Medicine Hospitals in China

Spatz

Wang

Beckman

et al. 2018

Circ: Cardiovascular Quality and Outcomes

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Traditional Chinese Medicine for Acute Myocardial Infarction in Western Medicine Hospitals in China

Spatz

Wang

Beckman

et al. 2018

Circ: Cardiovascular Quality and Outcomes

View full text Add to dashboard Cite

show abstract

“…Although the morbidity and mortality of MI have been controlled to a large extent with early and effective preventive measures and interventions, there are still some problems in secondary prevention and rehabilitation of patients with MI. Chinese medicine (CM) shows some advantages in these aspects, such as improving the quality of life (QOL) and decreasing the rate of adverse events (Xu-Feng et al, 2010; Duan et al, 2012; Zhang Y.H., 2014). Several clinical studies with breviscapine have reported its effects on MI.…”

Section: Breviscapine For the Treatment Of Clinical Cvdsmentioning

confidence: 99%

Therapeutic Effects of Breviscapine in Cardiovascular Diseases: A Review

Gao

Chen

et al. 2017

Front. Pharmacol.

View full text Add to dashboard Cite

Breviscapine is a crude extract of several flavonoids of Erigeron breviscapus (Vant.) Hand.-Mazz., containing more than 85% of scutellarin, which has been traditionally used in China as an activating blood circulation medicine to improve cerebral blood supply. Accumulating evidence from various in vivo and in vitro studies has shown that breviscapine exerts a broad range of cardiovascular pharmacological effects, including vasodilation, protection against ischaemia/reperfusion (I/R), anti-inflammation, anticoagulation, antithrombosis, endothelial protection, myocardial protection, reduction of smooth muscle cell migration and proliferation, anticardiac remodeling, antiarrhythmia, blood lipid reduction, and improvement of erectile dysfunction. In addition, several clinical studies have reported that breviscapine could be used in conjunction with Western medicine for cardiovascular diseases (CVDs) including coronary heart disease, myocardial infarction, hypertension, atrial fibrillation, hyperlipidaemia, viral myocarditis, chronic heart failure, and pulmonary heart disease. However, the protective effects of breviscapine on CVDs based on experimental studies along with its underlying mechanisms have not been reviewed systematically. This paper reviewed the underlying pharmacological mechanisms in the cardioprotective effects of breviscapine and elucidated its clinical applications.

show abstract

“…But evidence from other research suggested that because of the long-term therapeutic effect of TCM, the number of readmissions and total expenses of treatment reduced with the participant of Chinese medical treatment [ 22 ]. For example, in the TCM treatment of acute myocardial infarction, the readmission rate due to angina during the 6-month follow-up in the treatment group (2.96%) was significantly lower than that in the control group (7.88%) [ 23 ]. Therefore, TCM dominant diseases are ubiquitous and need us to excavate through research.…”

Section: Discussionmentioning

confidence: 99%

Analysis of the Characteristics of Dominant Diseases in Traditional Chinese Medicine: Based on 95 Diseases

Liang

et al. 2022

Evidence-Based Complementary and Alternative Medicine

View full text Add to dashboard Cite

Background. Traditional Chinese medicine (TCM) has been widely used all over the world and has shown its superiority in some diseases. However, there are no clear evaluation criteria for TCM. In 2019, a list of TCM dominant diseases was published by the Chinese National Administration of Traditional Chinese Medicine. This study aimed to systematically summarize the characteristics of 95 TCM dominant diseases and provide a reference for the establishment of evaluation criteria for TCM dominant diseases. Methods. The diagnosis and treatment protocols of all the 95 TCM dominant diseases were screened. The data of disease classification, diseases’ code of TCM, length of hospital stay, treatment protocols, and clinical pathways were reviewed and summarized. Results. The diseases of the genitourinary and nervous systems accounted for 14.74% and 12.73% of the TCM dominant diseases, respectively. The length of hospital stay for 55 (57.89%) diseases was no more than less than 14 days. Each disease had its specific Chinese herbal decoction pieces and Chinese patent drugs. Chinese medical injections were not widely used. TCM external treatments for these diseases are abundant, with hundreds optional. Conclusion. Some potentially promising TCM dominant diseases remain to be identified and deserve further research to establish the evaluation criteria of TCM dominant diseases.

show abstract

Clinical efficacy of traditional chinese medicine on acute myocardial infarction—A prospective cohort study

Abstract: CM therapy could decrease CM syndrome scores and blood-stasis syndrome score, reduce the rehospitalization rate during 6-month follow-up due to angina. Heart dysfunction and diabetes mellitus were hazard factors to end-point, whereas CM, PCI and ACE inhibitors were protective factors.

Cited by 8 publications

References 3 publications

Traditional Chinese Medicine for Acute Myocardial Infarction in Western Medicine Hospitals in China

Traditional Chinese Medicine for Acute Myocardial Infarction in Western Medicine Hospitals in China

Therapeutic Effects of Breviscapine in Cardiovascular Diseases: A Review

Analysis of the Characteristics of Dominant Diseases in Traditional Chinese Medicine: Based on 95 Diseases

Contact Info

Product

Resources

About